Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB‐NHL03 Trial—A Report From the Japan Children's Cancer Group
Masahiro Sekimizu(Nagoya Medical Center), Shosuke Sunami(Japanese Red Cross Narita Hospital), Keizo Horibe(National Hospital Organization), Atsuko Nakazawa(Saitama Children's Medical Center), Ryōji Kobayashi(Kagawa University), Katsuyoshi Koh(Saitama Children's Medical Center), Hiroko Fukushima(University of Tsukuba Hospital), Masahito Tsurusawa(Aichi Medical University), Yuki Yuza(Tokyo Metropolitan Children's Medical Center), Tetsuya Takimoto(National Center For Child Health and Development), Yasuhiro Takeshima(Hyogo University), Tomoyuki Watanabe(Aichi Gakuin University), Akiko Saito(Nagoya University Hospital), Tadashi Anan(Kumamoto University), Hiroyoshi Watanabe(Tokushima University), Koichi Ohshima(Kurume University), Tetsuya Mori(St. Marianna University School of Medicine), Takeshi Mori(Kyushu University)
Cited by 0
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426
Pharmacology of Protein Kinase Inhibitors
|The Annual Review of Pharmacology and Toxicology|1992|366